Search research articles
Contact Us
Filters
Showing results (201-210 of 283) with videos related to
Page
of 29
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
February 7, 2024
Fully automated measurement of plasma Aβ42/40 and p-tau181: Analytical robustness and concordance with cerebrospinal fluid profile along the Alzheimer's disease continuum in two independent cohorts
Giovanni Bellomo, Sherif Bayoumy, Alfredo Megaro, et al.
Clinical Chemistry and Laboratory Medicine
|
December 14, 2006
Analytical performance and clinical utility of the INNOTEST PHOSPHO-TAU181P assay for discrimination between Alzheimer's disease and dementia with Lewy bodies
Hugo Vanderstichele, Karen De Vreese, Kaj Blennow, et al.
Scientific Reports
|
June 22, 2019
The levels of the NMDA receptor co-agonist D-serine are reduced in the substantia nigra of MPTP-lesioned macaques and in the cerebrospinal fluid of Parkinson's disease patients
Tommaso Nuzzo, Daniela Punzo, Paola Devoto, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
April 7, 2011
Cerebrospinal fluid Tau/α-synuclein ratio in Parkinson's disease and degenerative dementias
Lucilla Parnetti, Davide Chiasserini, Gianni Bellomo, et al.
Annals of Clinical and Translational Neurology
|
October 17, 2019
Hippocampal epileptogenesis in autoimmune encephalitis
Michele Romoli, Paraskevi Krashia, Arjune Sen, et al.
Frontiers in Psychiatry
|
December 12, 2022
Educational interventions to improve detection and management of cognitive decline in primary care-An Italian multicenter pragmatic study
Gemma Lombardi, Elena Chipi, Domenico Arenella, et al.
Plos One
|
November 13, 2012
Differential sialylation of serpin A1 in the early diagnosis of Parkinson's disease dementia
Sarah Jesse, Stefan Lehnert, Olaf Jahn, et al.
Nature Reviews. Neurology
|
December 17, 2014
Cerebrospinal fluid biomarkers in trials for Alzheimer and Parkinson diseases
Alberto Lleó, Enrica Cavedo, Lucilla Parnetti, et al.
Stroke
|
July 10, 2019
Long-Term Risk of Stroke After Transient Global Amnesia in Two Prospective Cohorts
Michele Romoli, Maria Assuncao Tuna, Iain McGurgan, et al.
Epilepsia
|
December 18, 2025
Neuronal hyperexcitability: A key to unraveling hippocampal synaptic dysfunction in Lafora disease
Cinzia Costa, Laura Bellingacci, Jacopo Canonichesi, et al.
Page
of 29
Search research articles
Search
Showing results (201-210 of 283) with videos related to
Sort By:
Page
of 29
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
February 7, 2024
Fully automated measurement of plasma Aβ42/40 and p-tau181: Analytical robustness and concordance with cerebrospinal fluid profile along the Alzheimer's disease continuum in two independent cohorts
Giovanni Bellomo, Sherif Bayoumy, Alfredo Megaro, et al.
Clinical Chemistry and Laboratory Medicine
|
December 14, 2006
Analytical performance and clinical utility of the INNOTEST PHOSPHO-TAU181P assay for discrimination between Alzheimer's disease and dementia with Lewy bodies
Hugo Vanderstichele, Karen De Vreese, Kaj Blennow, et al.
Scientific Reports
|
June 22, 2019
The levels of the NMDA receptor co-agonist D-serine are reduced in the substantia nigra of MPTP-lesioned macaques and in the cerebrospinal fluid of Parkinson's disease patients
Tommaso Nuzzo, Daniela Punzo, Paola Devoto, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
April 7, 2011
Cerebrospinal fluid Tau/α-synuclein ratio in Parkinson's disease and degenerative dementias
Lucilla Parnetti, Davide Chiasserini, Gianni Bellomo, et al.
Annals of Clinical and Translational Neurology
|
October 17, 2019
Hippocampal epileptogenesis in autoimmune encephalitis
Michele Romoli, Paraskevi Krashia, Arjune Sen, et al.
Frontiers in Psychiatry
|
December 12, 2022
Educational interventions to improve detection and management of cognitive decline in primary care-An Italian multicenter pragmatic study
Gemma Lombardi, Elena Chipi, Domenico Arenella, et al.
Plos One
|
November 13, 2012
Differential sialylation of serpin A1 in the early diagnosis of Parkinson's disease dementia
Sarah Jesse, Stefan Lehnert, Olaf Jahn, et al.
Nature Reviews. Neurology
|
December 17, 2014
Cerebrospinal fluid biomarkers in trials for Alzheimer and Parkinson diseases
Alberto Lleó, Enrica Cavedo, Lucilla Parnetti, et al.
Stroke
|
July 10, 2019
Long-Term Risk of Stroke After Transient Global Amnesia in Two Prospective Cohorts
Michele Romoli, Maria Assuncao Tuna, Iain McGurgan, et al.
Epilepsia
|
December 18, 2025
Neuronal hyperexcitability: A key to unraveling hippocampal synaptic dysfunction in Lafora disease
Cinzia Costa, Laura Bellingacci, Jacopo Canonichesi, et al.
Page
of 29